6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
US6184229A · kind A · utility
0Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2000 |
| Grant date | Feb 6, 2001 |
| Priority date | — |
| Expiry date | Jan 7, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compound corresponding to the general formula (I) ##STR1## in which R.sub.1 represents a hydrogen atom, a (C.sub.1 -C.sub.4)alkyl group or a phenyl(C.sub.1 -C.sub.4)alkyl group, R.sub.2 represents a hydrogen atom or a (C.sub.1 -C.sub.4) alkyl group, and R.sub.3, R.sub.4 and R.sub.5 each represent a hydrogen or halogen atom or a trifluoromethyl, cyano, hydroxyl, (C.sub.1 -C.sub.6)alkyl or (C.sub.1 -C.sub.6) alkoxy group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.